Orthodontically induced inflammatory root resorption. Part I: The basic science aspects.
Orthodontically induced inflammatory root resorption (OIIRR) or, as it is better known, root resorption, is an unavoidable pathologic consequence of orthodontic tooth movement. It is a certain adverse effect of an otherwise predictable force application. Although it is rarely serious, it is a devastating event when it is radiographically recognized. Orthodontics is probably the only dental specialty that actually uses the inflammatory process as a means of solving functional and esthetic problems. Force application initiates a sequential cellular process. We know exactly how and when it is evoked, but we are unable to predict its actual overall outcome. The extent of this inflammatory process depends on many factors such as the virulence or aggressiveness of the different resorbing cells, as well as the vulnerability and sensitivity of the tissues involved. Individual variation and susceptibility, which are related to this process, remain beyond our understanding. We are therefore unable to predict the incidence and extent of OIIRR after force application. This contemporary review is divided into two parts. In Part I, we discuss the basic sciences aspects of OIIRR as a continuation of our previously published work. In Part II, we present the clinical aspects of this subject.
Brezniak
Naphtali
N
Israel Defense Forces, Tel-Hashomer.
Wasserstein
Atalia
A
D000818:Animals; D025021:Cementogenesis; D003739:Dental Cementum / Q000502:physiology; D003799:Dental Stress Analysis; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000503:physiopathology; D009967:Orthodontic Appliances / Q000009:adverse effects; D009971:Orthodontics, Corrective / Q000009:adverse effects*; D010010:Osteoclasts / Q000502:physiology; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D012391:Root Resorption / Q000209:etiology* / Q000503:physiopathology* / Q000517:prevention & control; D013974:Thyroxine / Q000627:therapeutic use
D004164:Diphosphonates; D011448:Prostaglandin Antagonists; D013974:Thyroxine